Predictive immune markers in advanced melanoma patients treated with ipilimumab
Myeloid-derived suppressor cells (MDSCs) and chronic inflammatory factors induce immunosuppression and disease progression in advanced melanoma patients. They could serve as important markers allowing the identification of patients with high risk of melanoma progression as well as the detection of t...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
28 Jun 2016
|
| In: |
OncoImmunology
Year: 2016, Volume: 5, Issue: 6 |
| ISSN: | 2162-402X |
| DOI: | 10.1080/2162402X.2016.1158901 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1080/2162402X.2016.1158901
|
| Author Notes: | Viktor Umansky, Jochen Utikal and Christoffer Gebhardt |
| Summary: | Myeloid-derived suppressor cells (MDSCs) and chronic inflammatory factors induce immunosuppression and disease progression in advanced melanoma patients. They could serve as important markers allowing the identification of patients with high risk of melanoma progression as well as the detection of those patients who may benefit from the therapy with ipilimumab. |
|---|---|
| Item Description: | Gesehen am 24.10.2019 |
| Physical Description: | Online Resource |
| ISSN: | 2162-402X |
| DOI: | 10.1080/2162402X.2016.1158901 |